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ABSTRACT 
The diversity of industrially important chemicals that can be produced 
biocatalytically from renewable resources continues to expand with the aid of 
metabolic and pathway engineering. In addition to biofuels, these chemicals also 
include a number of monomers with utility in conventional and novel plastic 
materials production. Monomers used for polyamide production are no exception, 
as evidenced by the recent engineering of microbial biocatalysts to produce 
cadaverine, putrescine, and succinate. In this thesis the repertoire and depth of 
these renewable polyamide precursors is expanded upon through the engineering 
of a novel pathway that enables Escherichia coli to produce, as individual 
products, both δ-aminovaleric acid (AMV) and glutaric acid when grown in 
glucose mineral salt medium. δ-Aminovaleric acid is the monomeric subunit of 
nylon-5 homopolymer, whereas glutaric acid is a dicarboxylic acid used to 
produce copolymers such as nylon-5,5. These feats were achieved by increasing 
endogenous production of the required pathway precursor, L-lysine.  E. coli was 
engineered for L-lysine over-production through the introduction and expression 
of metabolically deregulated pathway genes, namely aspartate kinase III and 
dihydrodipicolinate synthase, encoded by the feedback resistant mutants lysC
fbr
 
and dapA
fbr
, respectively. After deleting a natural L-lysine decarboxylase, up to 
1.6 g/L L-lysine could be produced from glucose in shake flasks as a result. The 
natural L-lysine degradation pathway of numerous Pseudomonas sp., which 
passes from L-lysine through both δ-aminovaleric acid and glutaric acid, was then 
ii 
 
functionally reconstructed in a piecewise manner in the E. coli L-lysine over-
producer. Expression of davBA alone resulted in the production of over 0.86 g/L 
AMV in 48 h. Expression of davBADT resulted in the production of over 0.82 g/L 
glutaric acid under the same conditions.  These production titers were achieved 
with yields of 69.5 and 68.4 mmol/mol of AMV and glutarate, respectively. 
Future improvements to the ability to synthesize both products will likely come 
from the ability to eliminate cadaverine by-product formation through the deletion 
of cadA and ldcC, genes involved in E. coli’s native lysine degradation pathway. 
Nevertheless, through metabolic and pathway engineering, it is now possible 
produce the polyamide monomers of δ-aminovaleric acid and glutaric acid from 
renewable resources.   
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Chapter 1 
BACKGROUND AND MOTIVATION 
1.1 Introduction 
In a global economy with a strong and continuing dependence on 
petroleum, long-term sustainability, environmental, and national security concerns 
provide compelling motivation for the development of renewable sources of fuels, 
chemicals, and materials. Through the rational re-engineering of microbial 
metabolism ‘microbial chemical factories’ can be constructed to convert biomass 
feedstocks (e.g., glucose, sucrose, fructose) into chemical products of high value 
and/or utility as greener and more sustainable alternatives to petrochemicals 
(Carothers et al., 2009;Martin et al., 2009).  These biocatalytic processes, in 
general, are positive technologies that operate at near ambient temperature and 
pressure in aqueous solutions with reduced energetic costs, and neutral or even 
positive environmental impacts.  This approach has already led to significant and 
recent improvements to the production of renewable fuels (Peralta-Yahya and 
Keasling;Atsumi et al., 2008;Atsumi and Liao, 2008;Schirmer et al., 2010;Steen 
et al.;Mendez-Perez et al., 2011;Rude et al., 2011), chemicals (Wierckx et al., 
2005;Qian et al., 2009b;Kind et al., 2010a;Schirmer et al., 2010;Whited et al., 
2010), and active pharmaceutical ingredients (Ro et al., 2006;Leonard et al., 
2009;Tsuruta et al., 2009;Campbell and Vederas, 2010). However, as roughly 331 
million barrels of liquid petroleum gases and natural gas liquids, and close to 11 
2 
 
billion ft
3
 of natural gas were used to produce plastics in the United States alone 
in 2006 (U.S. Energy Information Administration, 2011), interest in developing 
renewable and ‘greener’ plastic products is also increasing. Key accomplishments 
wherein metabolic and pathway engineering has been applied to develop 
renewable ‘biomonomers’ will now be briefly highlighted to provide a framework 
for the research presented herein. 
 
1.2 Metabolic Engineering for Naturally-Occurring Biopolymers and 
Biomonomers 
In addition to re-engineering cellular metabolism to produce useful fuels 
and chemicals, the same strategies have also lead to the production of natural and 
non-natural biopolymers and biomonomers. Bioplastics production can positively 
impact the carbon cycle through the consumption of atmospheric CO2 during 
feedstock cultivation. Since the global demand for bioplastics is predicted to triple 
by 2015, reaching over 1 million metric tons per year and a $2.9 billion market 
(Freedonia Group, 2009), the field is ripe for development. 
 
1.2.1 Naturally-Occurring Biopolymers   
A number of naturally-occurring biopolymers are known to be produced 
by microorganisms from renewable resources, most notably 
polyhydroxyalkanoates or PHAs, which have been extensively reviewed 
(Braunegg et al., 1998;Chen, 2009;Keshavarz and Roy, 2010).  PHAs, which are 
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biodegradable polyesters composed primarily of monomer subunits of (R)-3-
hydroxybutyrate (3HB), are produced as carbon and energy storage molecules by 
numerous different microbes. Well-studied examples of bacterial PHA producers 
include species of Ralstonia (Reinecke and Steinbuchel, 2009), Bacillus (Singh et 
al., 2009), and Pseudomonas (Rojas-Rosas et al., 2007), as well as phototrophic 
cyanobacteria (Asada et al., 1999).   While PHAs are produced efficiently by 
microbes via naturally evolved pathways, expressing the requisite pathway 
enzymes from various natural producers has also enabled their production at high 
levels in recombinant Escherichia coli, a more tractable host platform (Schubert 
et al., 1988).  All told, bacteria have been engineered to achieve PHA biosynthesis 
at up to 80% of cell dry weight and at productivities as high as 4 g/L-h from 
substrates such as glucose (Lee et al., 1999).   
Despite their numerous advantages, however, PHA production also suffers 
from numerous inherent shortcomings which may ultimately impede their long-
term and wide-spread utility.  For instance, while their biodegradable nature can 
help reduce municipal waste, this attribute renders PHAs unsuitable for use in 
applications requiring long term durability and/or environmental exposure.  As all 
PHAs are thermoplastic polyesters the achievable range of physicochemical and 
material properties are limited.  PHA chain length and purity are difficult to tune 
and control in an in vivo setting.  Lastly, because they are macromolecules, PHAs 
do not diffuse out from cells, but rather accumulate only intracellularly as 
cytosolic inclusion bodies.  Thus, since PHAs can only be harvested after the 
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microbial biocatalyst is lysed, continuous bioprocessing of PHAs remains 
unviable. 
 
1.2.2 Naturally-Occurring Biomonomers 
Limitations associated with naturally-occurring bioplastics such as PHAs 
have motivated a recent shift in focus to the alternative production of 
‘biomonomers’.  Biomonomers are small molecules (i.e., monomeric subunits) 
that can undergo ex situ chemocatalytic polymerization to produce plastics.  This 
strategy offers several distinct advantages.  First, since most biomonomers are 
often naturally excreted from microorganisms the need for cell collection and 
lysis is eliminated which greatly reduces operating expenditures and facilitates 
downstream product recovery.  Polymerization of biomonomers in highly 
controlled chemocatalytic environments leads to bioplastics with finely tuned and 
predictable properties and at high purities to satisfy quality control specifications.  
Lastly, the co-polymerization of biomonomers together with other monomers (of 
biological origin or otherwise) increases the diversity of renewable plastics to 
achieve a wider possible range of chemistries and properties.    
In general, there are two classes of biomonomers of industrial interest.  
The first are produced from natural metabolites with the aid of simple catalytic 
post-processing.  For example, the natural fermentation product ethanol can 
undergo dehydration to ethylene over a solid acid catalyst (Takahara et al., 
2005;Hu et al., 2010), before later being polymerized to poly(ethylene) or its co-
5 
 
polymers. The second class of biomonomers, which will be the specific focus of 
this review, are those metabolites that are themselves directly suitable for 
polymerization into bioplastics. Microbial production of biomonomers as ‘drop in 
compatible’ replacements to their petroleum-derived counterparts is advantageous 
as it provides a seamless interface between emerging biotechnologies and the 
existing polymer industry. This strategy ensures that decades of technological 
expertise and existing process infrastructure can be efficiently leveraged, and 
effectively enables conventional chemical and plastics processing to ‘pick up 
where biology leaves off’.   
The most prominent example of a naturally-occurring biomonomer is 
perhaps L(+)-lactic acid, whose polymerization leads to the polyester poly(lactic 
acid), or PLA.  L(+)-Lactic acid is a natural fermentation product of numerous 
microbes, of which prominent examples include lactic acid bacteria (including 
numerous Lactobacilli sp.) and filamentous fungi (Kosakai et al., 1997;Zhou et al., 
1999).  Microbial lactic acid production has been extensively reviewed in the past 
(Wee et al., 2006;Reddy et al., 2008).  Meanwhile, E. coli has also been 
engineered to over-produce both L(+)- (Zhou et al., 1999) and D(-)- (Zhou et al., 
2003;Mazumdar et al., 2010) stereroisomers of lactic acid as optically pure 
products.  This is important because lactic acid stereochemistry greatly controls 
the physical properties of PLA including, for example, crystallinity and in turn 
melting point (Lunt, 1998;Sodergard and Stolt, 2002).   
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A second naturally-occurring biomonomer that has been extensively 
investigated to date is succinic acid.  This 4-carbon diacid is a natural 
fermentation product of numerous bacteria, including Actinobacillus 
succinogenes, Anaerobiospirillum succiniciproducens, and Mannheimia 
succiniciproducens, which have been reviewed elsewhere (Song and Lee, 2006).  
Moreover, E. coli’s metabolism has again also been extensively engineered to 
over-produce this minor fermentation product to near theoretical yields (Thakker 
et al., 2012).  As microbial succinic acid production is now becoming a mature 
technology, several producers, including BioAmber (Plymouth, MN) and Myriant 
(Quincy, MA), are now developing commercial scale fermentation processes.  
Succinic acid is particularly useful for producing both polyesters and polyamides, 
and the first commercial bioplastics derived from this biomonomer will likely be 
poly(butylene-co-succinate) (PBS) (Bechthold et al., 2008) and nylon-5,4 (Qian et 
al., 2009b). 
 
1.3 Metabolic Engineering for Novel Biomonomers 
Despite the potential advantages of using biomonomers to produce 
renewable plastics, a limited pool of useful naturally-occurring metabolites 
ultimately constricts the diversity of bioplastics that can be produced by this 
approach. However, by applying metabolic engineering tools and strategies, de 
novo metabolic pathway engineering provides the potential to produce non-
natural biomonomers, and novel bioplastics, that were never before possible.   
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For example, styrenics are a family of polymers and co-polymers that use 
styrene or substituted styrene as a key monomer building-block. Today, nearly 60% 
of styrene’s global annual production (about 6 million tons in the U.S. 
manufacturers and 24 million tons globally), for example, supports plastics 
production (SRI, 2010). The recent engineering of novel enzymatic routes to both 
p-hydroxystyrene (pHS) and styrene and from glucose (Figure 1), however, may 
soon enable their renewable production.  
 
 
 
 
 
 
 
 
 
Figure 1: Novel pathways engineered for the production of p-hydroxystyrene and 
styrene from renewable glucose. 
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The first styrenic biomonomer to be synthesized from renewable resources 
was pHS (Qi et al., 2007). Its innate optical properties make pHS useful for 
producing photoresist polymers used in semiconductor manufacturing, for 
example (Pawlowski et al., 1991).   As seen in Figure 4, the engineered pHS 
biosynthesis pathway stemmed from L-tyrosine as its immediate endogenous 
precursor.  Only two enzymatic steps were then required to convert L-tyrosine to 
pHS.  First, the bi-functional phenylalanine/tyrosine ammonia lyase (PAL/TAL) 
of the yeast Rhodotorula glutinis catalyzed p-coumaric acid formation. Then, p-
coumaric acid was subsequently decarboxylated by phenylacrylate decarboxylase 
of either Bacillus subtilis (encoded by pdc) or Lactobacillus plantarum (encoded 
by padC).  Initial E. coli strains expressing the pHS pathway achieved final titers 
as high as only 400 mg/L.  Accumulation beyond this mark was severely limited 
as a result of pHS toxicity imposed on the E. coli host (Qi et al., 2007).  To 
overcome toxicity limitations, the well-known aromatic-tolerant Pseudomonas 
putida S12 was next investigated as a pHS production platform.  Utilizing two 
strains derived from P. putida S12 to overproduce precursor L-tyrosine as hosts, 
the pHS pathway was introduced.  Due to the innate ability of P. putida S12 to 
degrade numerous aromatic solvents, multiple competing pathway genes were 
also targeted for deletion.  These included both smo, which encodes styrene 
monooxygenase, and fcs, the first gene in the p-coumaric acid degradation 
pathway.  All told, engineered P. putida S12 strains were able to reach and 
tolerate pHS titers as high as 545 mg/L, nearly a 50% improvement. 
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More recently, our own group engineered a novel enzymatic pathway to 
enable E. coli to produce styrene directly from glucose (McKenna and Nielsen, 
2011). The styrene biosynthetic pathway is analogous to the pHS pathway (Figure 
1), except in that it stems from L-phenylalanine as its endogenous precursor and 
as such requires different pathway enzyme ‘parts’.  In this case, L-phenylalanine 
ammonia lyase (PAL) first converts L-phenylalanine to trans-cinnamic acid which 
is then decarboxylated to styrene.  Upon screening numerous enzyme candidates, 
it was ultimately found that PAL2 from Arabidopsis thaliana and FDC1 from 
Saccharomyces cerevisiae were most effective for these steps, respectively.  By 
over-expressing PAL2 and FDC1 in a L-phenylalanine over-producing E. coli 
host, styrene titers as high as 264 mg/L were achieved.  As with pHS, styrene 
titers too approached E. coli’s toxicity limit (~300 mg/L) and must similarly be 
overcome if economical styrene biomonomer production is to be achieved. 
More examples in recent years of metabolic and pathway engineering’s 
influence on biomonomer production includes the enantiomerically pure 
hydroxyacids. Hydroxyacids can serve as biomonomers to derive renewable 
polyesters.  Hydroxyacids of prominent interest to bioplastics applications include 
terminal hydroxyacids such as 3-hydroxypropionate (3HP) as well as the β-
hydroxyacids 3-hydroxybutyrate (3HB) and 3-hydroxyvalerate (3HV).  Each of 
these hydroxyacid monomers have been produced microbially from renewable 
resources via pathway engineering. 
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3HP was named one of the twelve ‘Top Value Added Chemicals from 
Biomass’ (U.S. Department of Energy, 2004) by the Department of Energy. In 
addition to serving as polyester monomer, 3HP can also be used to produce 
several other specialty and commodity chemicals through additional 
chemocatalytic processing (Rathnasingh et al., 2009). While several distinct 
enzymatic routes have been proposed for microbial 3HP production (Jiang et al., 
2009), two have demonstrated the greatest promise to date. The first was a two-
step pathway consisting of: 1) an adenosylcobalamin dependent glycerol 
dehydratase to catalyze the dehydration of glycerol to 3-hydroxypropionaldehyde 
(3HPA), and 2) an aldehyde dehydrogenase to oxidize 3HPA to 3HP (Suthers and 
Cameron, 2000). Using this pathway, Rathnasingh and co-workers engineered E. 
coli to produce 38.7 g/L 3HP in a fed-batch bioreactor with glycerol as substrate. 
In their strain, glycerol dehydratase (DhaB) from Klebsiella pneumoniae DSM 
2026 and the α-ketoglutaric semialdehyde dehydrogenase (KGSADH) from 
Azospirillum brasilense were selected (Rathnasingh et al., 2009). A key 
shortcoming of this approach, however, was the uneconomical requirement for 
exogenous coenzyme-B12 supplementation. To address this limitation, E. coli 
was later engineered to produce 3HP from glucose in a coenzyme-B12-
independent manner.   
Microbial production of (R)-3HB by recombinant E. coli was first reported 
by Gao et al..  Their engineered pathway was composed of phaA and phaB from 
Ralstonia eutropha (a natural PHB producer), encoding β-ketothiolase and an (R)-
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specific 3-hydroxybutyryl-CoA (R-3HB-CoA) dehydrogenase, respectively, to 
convert endogenous acetyl-CoA to 3-HB-CoA through acetoacetyl-CoA (Figure 
5). The ptb-buk operon from Clostridium acetobutylicum was lastly co-expressed 
to convert R-3-HB-CoA to R-3HB (via R-3-hydroxybutyryl phosphate), and shake 
flask titers exceeding 2 g/L were demonstrated as a result (Gao et al., 2002).  
Tseng et al. later built upon these works, adding the ability to produce both (R)- 
and (S)- 3HB isomers with high stereoselectivity and increasing product titers 
(Tseng et al., 2009). Stereoselective control was achieved by utilizing two 
different enantioselective 3HB-CoA dehydrogenases: (R)-selective PhaB from R. 
eutropha and (S)-selective Hbd from Clostridium acetobutylicum.  (R)-3HB 
biomonomer, which is natural excreted from E. coli, can be used to make 
biodegradable PHB with well-controlled properties. (S)-3HB biomonomer, 
meanwhile, can be used to produce novel PHBs with new features and properties.  
Some useful diol monomers provide examples of short-chain monomers 
suitable for bioplastics applications that have been produced microbially via both 
natural and engineered pathways. For example, the four-carbon diol 2,3-
butanediol (2,3-BDO) is a natural fermentation product of many microbes, 
including many species of Klebsiella, Bacillus, and lactic acid bacteria (Voloch et 
al., 1985).  Microbial production of 2,3-BDO by both natural and engineered 
strains will not be discussed here, however, as it has been extensively reviewed 
over the years (Garg and Jain, 1995;Celinska and Grajek, 2009;Ji et al., 
2010;Nielsen et al., 2010;Ji et al., 2011).    More recent efforts have focused on 
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engineering microbes to produce the three-carbon diol 1,3-propanediol (1,3-PDO) 
and the four-carbon diol 1,4-butanediol (1,4-BDO). Both 1,3-PDO and 1,4-BDO 
are non-natural metabolites. Like 2,3-BDO, 1,4-BDO can be similarly converted 
to butadiene.  More importantly, however, both 1,3-PDO and 1,4-BDO are 
directly useful as biomonomers for the polyesters poly(propylene terephthalate) 
(PPT) and poly(butylene terephthalate) (PBT).   
While microbial production of 1,3-PDO has been recently and 
comprehensively reviewed (Nakamura and Whited, 2003;Sauer et al., 
2008;Saxena et al., 2009;Celinska, 2010), the engineering of E. coli to produce up 
to 18 g/L 1,4-BDO from glucose (as well as other substrates) was only recently 
reported for the first time (Yim et al., 2011).  Bioproduction of 1,4-BDO was 
accomplished through the development of two novel pathways, the design of 
which was facilitated using the SimPheny Biopathway Predictor; a design 
algorithm that considers chemical structure to predict possible routes from central 
metabolite precursors to end-product targets (Smolke, 2009).  It is also noted that 
both 1,4-BDO pathways include the common intermediate 4-hydroxybutyrate 
(4HB), a hydroxyacid.  As described, hydroxyacids are excellent precursors for 
polyester production.  Thus, by further leveraging this technology an additional, 
non-natural hydroxyacid building block could also be added to the list of potential 
polyester biomonomers.   
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1.3.1 Microbial Production of Polyamide Building Blocks 
Polyamides (i.e., nylons) are a class of plastics that balance mechanical 
strength and durability with chemical resistance, and which find extensive use as 
textiles and mechanical parts.  Polyamides are formed as homopolymers of 
terminal amino acids or as co-polymers via condensation of diamines with 
diacids, as illustrated in figure 2 below: 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The most common commercial polyamides are nylon-6 (a homopolymer 
of 6-aminohexanoic acid) and nylon-6,6 (a copolymer of adipic acid and 1,6-
hexanediamine) which account for more than 85-90% of the global market, which 
Nylon-R,R 
+ 2n H
2
O 
Nylon-R 
+ n H
2
O 
a)  
b)  
n 
Figure 2: General Polymerization Reactions a) Dicarboxylic acid molecules 
undergo polymerizing condensation reactions with diamine molecules. b) 
Identical monomers with an amino group and a carboxylic acid group at each 
terminus undergo a polymerizing condensation reaction. 
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will approach 6.6 million tons by 2015 (Nexant Chem Systems, 2009). As carbon 
chain length (typically 2 to 12) between amide bonds strongly influences material 
properties, a large diversity of polymers can be generated from a limited 
monomer pool by a combinatorial approach.  Figure 3 highlights the diversity of 
polyamides that can be produced from a small number of biomonomers.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Putrescine is the 4-carbon diamine counterpart to succinic acid.  DSM 
Engineering Plastics currently uses biologically-derived putrescine (derived from 
Figure 3: Examples of polyamides produced from combinations of C4-C6 
diamines, diacids, and amino acids. To date, molecules with names underlined 
have been produced microbially from renewable resources with the aid of 
metabolic engineering. 
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castor oil) to produce nylon-4,6 and nylon-4,10,  which are marketed as Stanyl™ 
and EcoPaXX™, respectively.  Although putrescine occurs as an amino acid 
biodegradation product, no natural over-producers have been discovered or 
isolated.  In E. coli, for example, putrescine can generate at low levels by two 
different pathways that stems from either L-arginine (through agmatine) or L-
ornithine (from L-glutamate) by SpeAB or SpeC and SpeF, respectively (Tabor 
and Tabor, 1985;Igarashi and Kashiwagi, 2000).  Several researchers have also 
taken to rationally engineering putrescine over-producing microbes.  For example, 
Qian et al. reported the development of a putrescine over-producing E. coli strain 
by increasing metabolite flux through L-ornithine (Qian et al., 2009a).  This was 
achieved by overcoming allosteric and transcriptional regulation of the L-
ornithine pathway at multiple levels through promoter replacements and genetic 
deletions. The transcriptional regulation of the L-ornithine biosynthesis pathway 
by L-arginine at the promoters PargCBH, PargD, and PargE was alleviated by 
replacement of these promoters with the strong Ptrc promoter. Additionally, 
PspeC and PsepF-potE (potE codes for the putrescine export protein) were 
replaced with Ptrc, relieving regulation of transcription caused by putrescine on 
PspeC, and increasing the concentration of potE, which increases putrescine 
export from the cell. Furthermore, the argI gene coding L-ornithine 
carbamoyltransferase was deleted, significantly reducing flux to L-arginine, and 
any allosteric or transcriptional regulation L-arginine caused. The result was an E. 
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coli strain capable of producing 24.2 g/L putrescine in fed-batch cultures in 
glucose media (Qian et al., 2009b).   
Corynebacterium glutamicum has also been engineered to over-produce 
putrescine by both the L-ornithine and L-arginine pathways, reaching up to 6 g/L 
with a plasmid based speC, L-ornithine decarboxylase from E. coli (Schneider 
and Wendisch, 2010).  In comparison, putrescine yields achieved by C. 
glutamicum via the L-arginine pathway were 40 times lower with adiA (L-
arginine decarboxylase) and speB (agmatinase) overexpressed, likely due to the 
production and allosteric inhibition of urea on adiA. (Schneider and Wendisch, 
2010) 
Just as putrescine, the 5-carbon diamine cadaverine also naturally occurs 
as an amino acid degradation product, though only at low levels in natural 
organisms.  In this case it is the decarboxylation of L-lysine, and not L-ornithine, 
that leads to cadaverine.  Polyamides derived from cadaverine possess such 
desirable properties as high melting points and low water absorption  (Kind and 
Wittmann, 2011).  In addition, nylon-5,4, nylon-5,5 and nylon-5,10 (co-polymers 
of cadaverine with succinic acid, glutaric, and sebacic acid, respectively) have 
been proposed as bio-based alternatives to conventional, petroleum-derived 
polyamides of similar properties (Kind and Wittmann, 2011;Qian et al., 2011a).  
Mimitsuka et al. were first to engineer a microbe for cadaverine 
production from glucose by inserting the acid inducible lysine decarboxylase 
(encoded by cadA) of E. coli into the genome of a L-lysine over-producing strain 
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of C. glutamicum, as seen in Figure 4 (Mimitsuka et al., 2007).  E. coli and C. 
glutamicum have since both been extensively engineered for its over-production 
from renewable substrates (Mimitsuka et al., 2007;Tateno et al., 2009;Kind et al., 
2010a;Qian et al., 2011a) at titers up to 9.6 g/L in E. coli and over 10 g/L in C. 
glutamicum  In both systems, the over-expression of lysine decarboxylase (cadA 
and ldcC of E. coli) in a L-lysine over-producing host were essential strategies. 
cadA was expressed in E. coli by Qian et. al, along with deletion of the following 
cadaverine degredation pathway enzymes: spermacetyl transferase, spermidine 
synthase, cadaverine oxidase, and putrescine aminotransferase coded by speG, 
speE, ygjG, and puuA, respectively (Qian et al., 2011b). Additional increases in 
cadaverine formation were achieved by the native promoter replacement of dapA 
(dihydrodipicolinate synthase) with Ptrc. Final titers by fed batch cultivation 
reached 9.61g/L of cadaverine. 
 In Mimitsuka et al.’s strain of C. glutamicum, the cadA gene was 
introduced in place of the hom gene on the chromosome, making a cadaverine 
producer, but also an L-homoserine auxotroph, which is less than ideal.  Kind et 
al. showed that it is the ldcC gene that is best for overexpression because of its 
physiological pH optimum (Kind et al., 2010b).  Codon-optimization of ldcC, and 
the addition of 1 mg/L pyridoxal (the cofactor of ldcC) helped further improve the 
yield of cadaverine in this strain to 0.17 g/g on glucose. Kind et al. further 
investigated the byproduct formation of the C. glutamicum cadaverine producing 
strains, and noted up to 20% of cadaverine being formed as N-acetylcadaverine 
18 
 
(Kind, 2010).  Genome-wide transcript analysis then identified a permease 
(named cg2893), as illustrated in Figure 3, whose deletion reduced cadaverine 
production by 90%.  Additionally, genome based overexpression of cg2893 
increased cadaverine yield by 20% and reduced N-acetylcadaverine formation by 
75% (Kind et al., 2011). This genome based overexpression was accomplished by 
replacing the natural promoter of cg1893 with the strong promoter of superoxide 
dismutase, Psod. The improved results come from the fact that export escapes 
cadaverine from allosteric inhibition of L-lysine decarboxylase and degradation 
into N-acetylcadaverine. Also, lysine excretion as a by-product was completely 
eliminated by the deletion of LysE, the lysine export protein in C. glutamicum, 
which is also illustrated in Figure 4. This deletion effectively increases the 
available intracellular lysine concentration subjected to decarboxylation. In a final 
tuning of the strain, the N-acetyltransferase was identified. Out of the 17 possible 
identified N-acetyltransferases, the deletion of NCgl1469 completely eliminated 
the N-acetylcadaverine formation  (Kind, 2010).  
Nylon homopolymers are produced from terminal amino acid monomers, 
the 4-carbon of which is 4- or γ-aminobutyrate (GABA).  GABA is naturally 
produced by many organisms by decarboxylation of L-glutamate via glutamate 
decarboxylase. Whereas a microbe that produces GABA directly from glucose 
has yet to be reported, GABA production has been investigated in strains 
expressing heterologous glutamate decarboxylase in media supplied with L-
glutamate.  
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Figure 4: Engineering cadaverine production in Corynebacterium glutamicum 
by i) over-expressing L-lysine decarboxylase (cadA), ii) disrupting L-lysine the 
exporter (lysE), and iii) over-expressing an identified cadaverine exporter 
(cg2893). 
 
 
 
 
 
 
 
 
 
 
 
 
 
For example, up to 5.5 g/L GABA was obtained from 10 g/L of 
monosodium glutamate in E. coli, wherein the glutamate decarboxylase encoded 
by gadB, and the GABA/Glutamate antiporter of gadC were expressed via 
plasmids (Le Vo et al., 2012).  This antiporter functionally excretes formed 
GABA simultaneously with the import of L-glutamate molecules. Additionally, 
the GABA aminotransferase gabT was deleted from the genome to prevent 
GABA from being degenerated and funneled into the tricarboxylic acid cycle. In 
another example, the glutamate decarboxylase from Lactobacillus planatarum 
ATCC 14917 was isolated and expressed in Lactobacillus sakei B2-16 with the 
use of the Lactobacilli-E. coli shuttle-expression vector pTRKH2 (Kook et al., 
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2010).  This yielded 27.4 g/L GABA in a media supplemented with 70 g/L of L-
glutamate. More work needs to be done in coupling the glutamate decarboxylase 
expression and activity demonstrated with a strain that has been proven to 
overproduce glutamate. 
As seen in earlier in Figure 3, bio-production of several other useful 
polyamide monomers has yet to be realized. There is a particular gap in the 
renewable production of homopolymer building blocks. GABA is the closest 
demonstration, but has yet to be demonstrated on glucose. Since this problem is 
currently being worked on, other impactful monomers that do not have a current 
proposed or demonstrated metabolic engineering strategy including the 5-carbon 
polyamide monomers δ-aminovaleric acid and glutaric acid. Rational engineering 
of microorganisms as cellular factories to produce these polyamide building 
blocks from renewable resources would push the biopolyamide field and 
biopolymer field in general, forward by filling these crucial gaps.  
 
1.4 Pathways to δ-Aminovalerate and Glutaric Acid Production 
Like cadaverine, the 5-carbon monomers δ-aminovalerate and diacid 
glutaric acid are known to be natural L-lysine degradation products.  Numerous 
Pseudomonas sp., for example, are known to degrade L-lysine through δ-
aminovaleric acid and on to glutaric acid via the AMV pathway, before it is then 
further degraded to central pathway metabolites. (Revelles et al., 2007) Thus, if 
select parts of the AMV pathway can be functionally reconstructed in an L-lysine 
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over-producing host, renewable routes to bio-based nylon-5 and nylon-5,5 could 
be possible.  The microbial production and subsequent polymerization of δ-
aminovalerate would yield Nylon 5.  While nylon-5 has not achieved commercial 
realization, it is known to possess properties close to nylon-4,6 and could serve as 
a suitable substitute (Bermudez et al., 2000). Glutarate can be polymerized with 
both putrescine and cadaverine, producing the completely sustainable nylon-4,5 
and nylon-5,5, respectively. In particular nylon-5,5 is an odd-odd polymer with 
additional piezoelectric and ferroelectric properties useful in sensors and 
electronics (Navarro et al., 1996). 
As is illustrated in Figure 5 below, there are many documented 
biochemical pathways that can convert renewable feedstocks into AMV and on to 
glutarate. Since the chemistry from AMV to glutarate is more straightforward, the 
options are either DavT or GabT, and DavD or GabD. These activities and 
production kinetics of the enzyme homologues from AMV to glutarate will be 
compared. For AMV production from L-lysine there are a number of options.  
DavB and DavA were deemed to be the most direct, and also are completely 
characterized in terms of gene sequences and enzyme chemistry (Revelles et al., 
2007). Thus the DavBA pathway was the first pathway attempted for cloning. 
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1.5 Research Objectives and Structure of Thesis 
To address the grand challenges of sustainability that faces our society, I 
envisioned applying the metabolic engineering toolbox to rationally engineer E. 
coli to produce both δ- aminovalerate and glutarate from glucose.  To accomplish 
this feat, three foreseeable challenges first had to be met. First, metabolite flux 
through the endogenous lysine had to be enhanced to provide adequate supply of 
the pathway precursor from glucose.  Second, appropriate enzymes constituting 
the production pathway had to be identified, introduced into E. coli, and 
characterized. Third, production of the compounds of interest from glucose had to 
be demonstrated by expressing the pathway genes in a lysine over-producing E. 
coli host. The last step then involved debottlenecking of the pathway and fine-
tuning of its enzymes in the final production strain. The work contained within 
this document constitutes the first demonstration of the bioproduction of δ-
aminovalerate and glutarate from glucose, and effectively expanding the 
repertoire of polyamide monomers that can be produced microbially from 
renewable resources. The last step then involved debottlenecking of the pathway 
and fine-tuning of its enzymes in the final production strain. The work contained 
within this document constitutes the first demonstration of the bioproduction of δ-
aminovalerate and glutarate from glucose, and effectively expanding the 
repertoire of polyamide monomers that can be produced microbially from 
renewable resources.  
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Figure 5: Multiple known biochemical pathways from L-lysine to δ-
aminovalerate and glutarate, and the previously engineered pathway to 
cadaverine. 
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This thesis consists of four chapters. Chapter 2 is a presentation of the 
analytical and experimental methods that were central to this research. Chapter 3 
presents the relevant results of this research, as well as critical analysis and 
discussion. Chapter 4 provides a summary of the work, along with conclusions 
and several recommendations for future work. These chapters are followed by an 
appendix and a list of all references. 
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Chapter 2 
MATERIALS AND METHODS 
 
2.1 Introduction 
 As discussed in Chapter 1, guiding E. coli’s metabolism through the 
introduction of exogenous biochemistry could potentially yield a polyamide 
building block production host. This chapter outlines the material and chemicals, 
enzymes, strains, plasmids, and cloning strategies used. This includes how various 
mutations were introduced through splicing overlap extension. The various 
pathway characterization methods and cellular culturing strategies in production 
hosts are also detailed. At times, it is necessary to provide some background as to 
why various experimental methods were employed. 
 
2.2 Chemicals and Enzymes 
Various organic acids were used as standards for analytical detection and 
as cofactors. Glutaric Acid (≥99%) in its free acid form and α-Ketoglutaric acid 
sodium salt (≥98%) were obtained from Sigma-Aldrich Co. (St. Louis, MO). The 
amino acids used for analytical standards and production kinetic experiments L-
lysine (≥97%) and δ-aminovalerate (≥97%)  were also obtained from Sigma-
Aldrich. The diamine cadaverine (MP Biomedical; Santa Ana, CA; ≥97%), D-(+)-
glucose (Amresco; Solon, OR; ≥99.5%) were used for analytics and culturing, 
respectively.  Glycerol (≥99%), and Yeast Extract were obtained from Sigma-
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Aldrich. The inorganics used as media components and buffers include 
(NH4)2SO4 (Sigma-Aldrich, ≥99%), MgSO4 (EMD Chemicals Inc.; Darmstadt, 
Germany; ≥99.5%), KH2PO4 (Amresco, ≥98%), CaCO3 (Sigma-Aldrich, ≥99%). 
The buffers used for resting cell assays, and nucleotide and protein gels were 
Phosphate Buffered Saline (PBS; Cellgro; Manassas, VA) buffer, Tris-Acetate-
EDTA (TAE; S-Prime; Gaithersburg, MD) buffer, and Tris/Glycine/SDS (Bio-
Rad; Hercules, CA) buffer. 
All DNA polymerases, ligases, restriction enzymes and buffers were 
purchased from New England Biolabs (Ipswich, MA). For routine DNA 
amplification taq DNA polymerase was used and for DNA cloning Phusion DNA 
polymerase was utilized. For all ligations T4 DNA ligase was utilized. The 
various restriction enzymes used for DNA digestion were: BamHI, BglII, EcoRI, 
NcoI, NheI, BspHI, and NdeI. All of the enzyme specific buffers were purchased 
from the same companies as the respective enzymes. 
 
2.3 Plasmid Construction and Cloning  
2.3.1 Strains and DNA Plasmids, Primers 
 
E. coli strains used in this study are listed in Table 1. E. coli strains 
NEB10β and 5-α F’Iq were used for general gene cloning. E. coli BW25113, a K-
12 strain, was used as a parent strain to develop lysine overproduction strain 
because of its tractability. For the construction of plasmids and strains, cells were 
grown in Luria-Bertani (LB) broth or on LB plates (1.5wt% agar) containing 
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appropriate antibiotics at the following concentrations: 50 mg L
-1
 Streptomycin 
(Sr), 50 mg L
-1
 Chloramphenicol (Cm), 100 mg L
-1
 Ampicillin (Amp), and 50 mg 
L
-1
 Kanamycin (Kan). 
Plasmids used in this study are also listed in Table 1. Polymerase chain 
reaction (PCR) primers (obtained from IDT; Coralville, IA) for plasmid 
construction and genetic engineering are listed in Table 2. For the overexpression 
of davB and davA, the davBA operon of P. putida KT2440 was amplified using 
Phusion polymerase and F_DavBA_EcoRI and R_DavBA_HindIII (Table 2). The 
PCR product was digested completely with EcoRI and HindIII. This fragment was 
ligated with EcoRI-HindIII digested plasmid pSTV28. For the overexpression of 
davT and davD, the davDT operon of P. putida KT2440 was amplified using 
Phusion polymerase and F_DavDT_EcoRI and R_DavDT_BglII. The PCR 
product was digested completely with EcoRI and BglII. The fragment was ligated 
with EcoRI-BamHI digested plasmid pTRC99a. BglII and BamHI are 
isoschizomers making their digested overlap regions palindromic and compatible 
for ligation. These constructed plasmids were named pSTVDavBA and 
pTRCDavDT, and allow for the gene expression under the strong, inducible trc 
promoters.  
To create a lysine overproducer, dapA from Corynebacterium glutamicum 
13032 was PCR amplified using F_dapA_NcoI and R_dapA_EcoRI. dapA is a 
naturally feedback resistant version of Aspartate kinase III. This amplicon was 
purified and digested with NcoI and EcoRI. This fragment was ligated with NcoI-
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EcoRI digested plasmid pCDFduet-1. LysC was made feedback resistant by 
introducing a mutation at the 1055 bp of the E. coli MG1655 lysC, aspartate 
kinase III. This was accomplished using splicing overlap extension. This is a well 
characterized method of introducing single point mutations in genes through 
properly designed primers. A PCR with F_lysC_NdeI and R_lysCmutation 
amplified an ~1150 bp segment of the gene. The primers (Table 2) 
F_lysCmtuation and R_lysC_BglII were used to introduce the mutation into an 
~450 bp segment. These two DNA amplicons were used as templates in another 
PCR which amplifies a mutated (feedback resistant) version of lysC. LysC
fbr
 was 
digested completely with NdeI and BgIII. NdeI-BglII digested pCDFdapA
fbr
 was 
ligated with digested lysC
fbr
.   
pCDFduet-1 was was chosen because pSTV99a and pTRC28 confer 
chloromphenocol and ampicillin resistance, respectively. pCDFduet-1 confers 
streptomycin resists, thus was a natural choice for screening experiments that is 
compatible in the presence of pSTV99a and/or pTRC28, or their derivative 
plasmids (i.e. pSTVDavBA). To confirm that these genes had been properly 
cloned into pCDFduet-1, PCR and digestion screening was employed. 
Additionally, to confirm that the appropriate mutation was introduced into the 
lysC gene via splicing overlap extension, the pCDFDapA
fbr
 and 
pCDFdapA
fbr
lysC
fbr
 were both sequenced at the Biodesign Institute at Arizona 
State University via their DNA sequencing process. 
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2.3.2 DNA Purification 
PCR amplified DNA fragments were purified using DNA Clean and 
Concentrator Kits(Zymo Research, Irvine, CA). Plasmid DNA was miniprepped 
and purified using Zyppy plasmid miniprep kits (Zymo Research). Cell harboring 
the plasmid of interest were cultured in 5mL LB with appropriate antibiotic 
overnight. The following day the kit was used to yield purified plasmid DNA in 
water for transformations, PCR, and digestions. Genomic DNA purification kits 
from Zymo Research Co. for all genomic template DNA extractions used for 
polymerase chain reactions and cloning was purified according to the genomic 
DNA purification kits. Gel DNA extraction kits from Zymo Research Co. were 
used on DNA samples that were to be used for ligation reactions were viewed and 
concentrated on nucleotide agarose gels. Agarose gel was cut out and the 
contained DNA was purified according to the Gel DNA purification kit.  
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Table 1: Bacterial strains and DNA plasmids used in this study 
 Strains/Plasmids Description
a
    
E. coli NEB10β     araD139∆(ara-leu)7697 fhuA lacX74 galK (ϕ80 
∆(lacZ)M15) mcrA galU recA1 endA1 nupG rpsL (StrR) 
∆(mrr-hsdRMS-mcrBC) 
 
E. coli 5-α F’Iq F  ´ proA
+
B
+
 lacI
q
 ∆(lacZ)M15 zzf::Tn10 (TetR) / 
fhuA2∆(argF-lacZ)U169 phoA glnV44 Φ80Δ(lacZ)M15 
gyrA96 recA1 relA1 endA1 thi-1 hsdR17 
E. coli BW25113 F’ λ
- ∆(araD-araB)567, ∆lacZ4787(::rrnB-3), lambda-, rph-
1, ∆(rhaD-rhaB)568, hsdR514 
E. coli ΔcadA BW25113ΔcadA (l-lysine decarboxylase) 
E. coli ΔldcC   BW25113ΔldcC (l-lysine decarboxylase) 
E. coli MG1655 F
-
 λ- ilvG- rfb- 50 rph-1 
P. putida KT2440 originates from the toluene degrading bacterium P. putida 
mt-2  
C. glutamicum             Gram-positive bacterium of the class Actinobacteria 
13032      
 
pTRC99a                     Expression vector,  Ampr, trc promoter, pBR322 Ori, 
4178 bp                            Ori, 4178 bp 
 
pSTV28              Expression vector, Cmr,  trc promoter, pACYC184 2999 
bp                                    Ori, 2999 bp 
 
pCDFDuet-1               Duet expression vector, Srr, T7 promoter, CDF            
Ori, 3781 bp                    Ori, 3781 bp 
 
pSTVDavBA               P. putida KT2440 davBA operon  in EcoRI-HindIII site  
of pSTV28                       of pSTV28 
 
pTRCDavDT           P. putida KT2440 davDT operon in EcoRI-BamHI site      
of pTRC99a                     of pTRC99a 
 
pTRCGabDT         E. coli MG1655 gabDT operon in EcoRI-BamHI site         
of pTRC99a                     of pTRC99a 
pCDFlysC
fbr
dapA
fbr
  E. coli MG1655 lysC gene in NdeI-BglII site and C.     
glutamicum 13032 dapAglutamicum 13032 dapA gene in NcoI-EcoRI site of 
pCDFduet-1 with an si pCDFduet-1 with a single base pair mutation at the  
1055bp (cytosine to thym1055bp (cytosine to thymine) 
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2.3.3Chemically Competent Cell Transformations 
Chemically competent cells were prepared by first preparing a seed culture grown 
in 5mL LB overnight. From this seed, 500µL was then used to inoculate 50mL 
LB in a 250mL shake flask, which was then grownat 37
 o
C and shaken at 200rpm 
Until reaching an OD600 of ~0.4. Cells were then collected by centrifuging at 
1600xg for 5 minutes and at 4
 o
C before then being washed with 10 mL of 60mM 
CaCl2. This wash step was repeated three times before the cells were then 
incubated on ice for 30 min. Cells were then again centrifuged before being 
resuspended in 2 mL 60mM CaCl2. This final solution was divided into 100 µL 
aliquots and stored in the -80
o
C. Transformations of chemically competent cells 
were performed by first allowing frozen cells thaw on ice for 15 minutes. Then, 
1µL of purified plasmid or 10µL of ligation reaction was added to cells and the 
mixture was allowed to incubate for another 15 minutes on ice. The mixture was 
then heat shocked at 42
˚
C for thirty seconds. Immediately after this heat shock 
step, 500µL Super Optimal Broth (SOC; Teknova; Hollister, CA) was added to 
the mixture, and plated on LB with appropriate antibiotics. 500µL Super Optimal 
Broth (SOC; Teknova; Hollister, CA) was added to the mixture and the sample 
was incubated in a 37
˚
C while shaking at 200 rpm for one hour before being 
plated on LB with appropriate antibiotics and incubating overnight at 37
o
C. 
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Table 2: DNA primers used in this study for PCR and Splicing Overlap Extension 
 
 
2.3.4 DNA Ligations and Digestions 
Ligations were performed according to the following recipe: 1µL T4 DNA 
ligase was mixed with 1µL T4 DNA ligase buffer, 4µL digested plasmid DNA, 
and 4µL digested DNA fragment making a 10µL ligation reaction. These 10µL 
ligation reaction mixtures were allowed to react for 16 hours or overnight at 4
o
C 
Primer                                          Sequence (5’—3’)a                                                   
F_DavBA_EcoRI      TATGAATTCCTAAGGGGAATATACATGAACAAGAAGAACCGCCACC                    
R_DavBA_HindIII   TTAAAGCTTTCAGCCTTTACG 
F_DavDT_EcoRI      TATGAATTCCTAAGGGGAATATACATGCAGCTCAAAGACGCTCA 
R_DavDT_BglII        TATAGATCTTCAGGCGATTC 
F_DapA_NcoI              CCCGGGCCATGGCTACAGGTTTAACAGCTAAGACCGGAGTAGA 
R_DapA_EcoRI        GATATCGAATTCTCATTATAGAACTCCAGCTTTTTTC 
F_LysC_NdeI               GATATCCATATGTCTGAAATTGTTGTCTCCAAATTTGGCGG 
R_LysC_BglII             GCGATTAGATCTTTACTCAAACAAATTACTATGCAGTTTTTG 
F_LysC_Mutation     GTGGCATTAATCCTTGATACC 
R_LysC_Mutation     GGTATCAAGGGTTAATGCCAC 
a) Restriction sites are underline 
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before transformation. T4 DNA ligase buffer was purchased from New England 
Biolabs (Ipswich, MA) 
Digestions were accomplished according to the following recipe: 32 µL 
Plasmid or PCR amplified DNA was mixed with 4µL Restriction Enzyme(s) and 
4µL Appropriate Restriction Enzyme Buffer making a 40µL ligation reaction. 
40µL restriction digestions were allowed to react for 3 hours at 37
˚
C, and 
digestion products were recovered by DNA gel purification. All restriction 
enzyme buffers were purchased from New England Biolabs 
 
2.4 Pathway Expression and Characterization 
Various methods were employed to characterize the pathway. First protein 
gels and Bradford assays were employed to discern the expression of the proteins 
and to get a feel for the amount of total protein that is being produced. Next, 
whole cell assays were done in order to get a feel for the functionality and kinetics 
of the various enzymes when fed substrates of the AMV pathway. 
 
2.4.1 Protein and Nucleotide Gel Electrophoresis 
Protein gels were run to determine that the appropriately cloned genes 
were successfully being translated. Appropriately cloned plasmids were 
transformed into a production strain of E. coli BW25113, which have the DE3 
prophage necessary to translate the RNA polymerase for the T7 promoter of the 
duet vectors (i.e. pCDFduet-1). Cells were given the DE3 prophage by following 
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the standard procedure of the Novagen λDE3 lysogenization kit (Darmstadt, 
Germany). These production strains were then cultured in 5mL LB with 
appropriate antibiotics. 500µL seeds were inoculated into 50mL LB with 
appropriate antibiotics and cultured at 37°C. After 3 hours 12.5µL 1M Isopropyl 
β-D-1-thiogalactopyranoside (IPTG) was added to growing cultures. Cultures 
were allowed to grow for 12 hours after addition of IPTG. Cells were then lysed, 
centrifuged, and protein lysates taken as the supernatant. 15 µL of the lysates 
were then stained with 15 µL a mixture of 118.75 µL lammeli buffer (Bio-Rad) 
and 6.25 µL 2-mercaptoethanol (Sigma-Aldrich, ≥98%). The lysates were then 
denatured at 100°C for 5 minutes. Premade 4-12% gradient polyacrylamide gels 
stored in NaN3, purchased from Bio-Rad were then placed vertically into the gel 
apparatus and stained samples injected into the wells. Protein gels were run at 
200V for 35minutes against a Precision Plus Protein Unstained Standard (Bio-
Rad). Protein gels were then washed with water, stained with 50mL Coomassie 
Brilliant Blue G-250 Solution (G-Biosciences, St. Louis, MO) for one hour and 
left to shake overnight in water. 
Nucleotide gels were prepared dissolving a ratio of 0.2g Agarose per 
25mL 1x TAE buffer and heating. The liquefied gel was poured into a gel tray 
and allowed to cool with a well comb. Samples were stained with Safe-View 
DNA white dye (abm Inc.; Richmond, BC) and ran against a New England 
Biolabs 1.0  kB DNA ladder prepared as 20µL Safe-View white dye, 20µL 1.0 kb 
DNA ladder, and 160µL 1x TAE. Gels were viewed on a UV block. 
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2.4.2 Bradford Assays 
For Bradford assays the protein lysates were prepared identically to that of 
a protein gel. A calibration curve was made using 0, 0.2, 0.4, 0.6, 0.8, and 1 g/L 
Bovine Serum Albumin (BSA) protein standards stained with Quick Start 
Bradford 1x Dye Reagent (Bio-Rad), vortexed, and allowed to stain for 10 
minutes. Optical Density (OD) at 595nm of these standard solutions was taken 
and made into a calibration curve. Lysates were then stained with Bio-Rad dye. 
The OD595 was measured, and the total protein concentration was back calculated 
based on the BSA calibration. 
 
 2.4.3 Whole Cell Kinetic Assays 
Appropriately cloned plasmids (i.e. pSTVDavBA, pTRCDavDt, 
pCDFDapA
fbr
, and/ or pCDFDapA
fbr
LysC
fbr
) were transformed into a production 
strain of E. coli BW25113, which has the DE3 prophage. These production strains 
were then grown overnight in 5mL LB with appropriate antibiotics (5µL). 500µL 
seeds of these overnight cultures inoculated 50mL LB with appropriate antibiotics 
and grown at 37˚C. After 3 hours 12.5µL 1M IPTG was added to growing 
cultures. Cultures were allowed to grow for an additional 12 hours. 50mL of cell 
culture was then spun down to a pellet at 1700g and washed twice with 10mL 
PBS. The pellet was finally resuspended in 30mL PBS and split into three 10mL 
samples in 15mL vials to run experiments in triplicate. Appropriate sterilized 
chemicals were fed to the resting whole cells for kinetic assays at that point at 
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various concentrations. Samples were taken for analytical quantification as 500µL 
samples, centrifuged at 2000g, and the supernatant removed from the pellet. This 
supernatant was either immediately analyzed by high pressure liquid 
chromatography or frozen at -20˚C for future analysis.  
 
 2.5 Culture Media 
Three types of culture media were used for this research: LB, SOC, and a 
production minimal media (M10). LB (company, state) media was used for seeds 
and routine growth of all E. coli strains with a composition of (per L): 10 g 
Tryptone, 5 g Yeast Extract, 10 g NaCl. SOC was used for cultivation of cells 
during chemically competent transformations. SOC has a composition of (per L): 
20 g Tryptone, 5 g Yeast Extract, 0.5 g NaCl, 0.186 g KCl, 0.952 g MgCl2, and 
3.603 g Glucose. M10 was used for production experiments. The recipe for M10 
is as follows (per L): 25 g Glucose, 16 g (NH4)2SO4, 1 g MgSO4, 1 g KH2PO4, 2 g 
Yeast Extract, 30 g CaCO3. When culturing with M10 media, prior to inoculation, 
seed cultures were always grown overnight in 5 mL LB. 500µL samples were 
then washed twice with 500µL 0.9% NaCl, and added into 50 mL M10 media in a 
250mL shake flask. Frozen stocks of all bacteria strains were prepared by 
growing up a seed culture in 5 mL LB over night at 37
°
C and combining in a 1:1 
(v/v) manner with a 30% (w/v) glycerol solution in tubes. These tubes were stored 
for up to 1 year in a -80
°
C freezer. Seed cultures prepared from frozen stock were 
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scraped from frozen stock with a pipette tip, and introduced to 5mL LB shaking at 
37
 °
C, 200rpm, and with appropriate antibiotics added.  
 
 
2.5.1 Toxicity Experimental Setup 
If the toxicity were too high it may be ineffective to attempt to produce 
these compounds with E. coli as a host. Here we define the toxicity limit as the 
point at which the rate of cellular growth is zero, and any further compound 
addition results in a negative cellular growth rate. (i.e. cell death). Seed cultures 
of BW25113 (a tractable E. coli strain for production of protein) The following 
day 900 µL of these seed cultures were centrifuged, and the pellets suspended in 
0.9% NaCl (filter sterilized). This wash step was repeated twice, a final 
resuspension was given, and used to inoculate 50 mL M10 media. Once the OD600 
reached 0.5, varying amounts of δ-aminovalerate and glutarate in water were 
added. At this point the experiment was underway and growth over time was 
monitored at OD600.  
 
  2.5.2 Assays for Lysine, AMV, and Glutarate Production  
In order to test various strains for engineered lysine, AMV, and/or 
glutarate production it is critical to use a minimal media with a limited amount of 
phosphate. Imaizumi et al. suggested the M10 media in their publications with E. 
coli WC196 and WC196R (mutagenized and evolved L-lysine overproducers). To 
detect various culture metabolites, seeds were cultured overnight in 5 mL LB with 
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appropriate antibiotics. These seeds were then washed with 0.9% NaCl. These 
washed seeds inoculated into 50 mL M10 media, after 3 h 12.5 µL 1M IPTG was 
added to the culture. Samples of the culture were taken periodically and the OD600 
read. Then the cells were centrifuged to a pellet, and the supernatant was taken for 
analysis including quantification of media components with time. These 
experiments were repeated in triplicate as 3x50 mL cultures in 250 mL shake 
flasks. 
 
2.6 Analytical Methods 
High pressure liquid chromatography (HPLC; 1100 series, Agilent, Santa 
Clara, CA) was used to examine aqueous concentrations of various L-lysine, 
AMV, cadaverine, glutarate, 2-oxoglutarate, and glucose. Samples thought to 
contain amino acids and diamines were first derivatized in-needle with o-
phthalaldehyde (OPA) (OPA Reagent Solution Complete, Sigma-Aldrich, St. 
Louis, MO) as described below, before being separated on a ThermoFischer 
Hypersil Gold aQ (Anthem, AZ), 150x 4.6mm column with 5µm diameter 
particles. A constant column temperature of 40
o
C was used. A 50/50 mixture of 
filtered and degassed deionized water and methanol (≥99.9%, HPLC grade, 
Sigma-Aldrich, St. Louis, MO) was used as the mobile phase at a constant flow 
rate of 0.77 mL/min. Analytes were detected using a Diode Array Detector 
(DAD) set at a wavelength of 338nm. Analyte concentrations were determined 
with the use of external standards for calibration. 
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OPA derivatization was required for the detection of each of lysine, 
cadaverine, and δ-aminovalerate . The thioisoindole reaction products absorb light 
maximally at 338nm (Qian et al. 2009b). Derivatization was accomplished by 
programmed mixing of cold OPA reagent with samples in a 3:1 (v/v) proportion, 
typically in a ratio of 6 µL analyte to 2µL OPA mixture, inside the auto-injector 
needle for one minute before injection.  
Organic acids (glutaric acid and 2-oxoglutarate) and glucose were 
separated using a Bio-Rad Aminex HPX-87H column, 300x7.8mm, with 9µm 
diameter particles (Hercules CA), operated at a constant temperature of 50
°
C and 
using a mobile phase of 0.005 M H2SO4. A Refractive Index Detector (RID) was 
used for analyte detection. Analyte concentrations were determined with the use 
of external standards for calibration. Injection volumes of 10 µL and detection 
time frames of 15 minutes were enough to detect all relevant culture components, 
and elute all components past the RID. 
 Cell growth was measured by means of changes in optical density (OD) as 
measured as the absorbance of 600nm light relative to a standard. A Beckman 
Coulter DU800 spectrophotometer was used (Brea, CA) The spectrophotometer 
was blanked using uninoculated media. Occasionally, for analysis of the OD600 of 
cultures grown in LB specifically, a Buglabs (Concord, CA) handheld OD 
Scanner was calibrated and used.  
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Chapter 3 
ENGINEERING E. COLI FOR THE PRODUCTION OF δ-AMINOVALERATE 
AND GLUTARATE FROM GLUCOSE 
3.1 Introduction 
 While the AMV pathway of P. putida KT2440 is naturally used for L-
lysine degradation, its piecewise and heterologous reconstruction could also 
provide a route to the renewable production of polyamide biomonomers δ-
aminovalerate and glutarate. Chapter 3 outlines and characterizes the ‘bottom up’ 
engineering of E. coli to produce both  δ-aminovalerate and glutarate through the 
rational engineering of a L-lysine over-producing host strain and functional 
reconstruction and characterization of the AMV pathway, followed by their 
ultimate integration to demonstrate their production directly from renewable 
glucose.  In addition, metabolite toxicity analyses were performed to understand 
the impacts of producing these chemicals on E. coli and to set targets for 
maximum achievable titers.   
3.2 Approach 
 Figure 6 illustrates the general approach followed in this study to engineer 
E. coli for  δ-aminovalerate and glutarate production from glucose. As shown in 
Figure 6, the complete AMV pathway is composed of four enzymes, DavBADT, 
which, as noted by Revelles et al. are organized into two operons (Revelles et al., 
2007). The genes davBA form one operon while davDT form the other. As seen in 
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Table 3, it was predicted that the AMV pathway enzymes should function well in 
E. coli due to the abundant of available cofactors that are conserved between the 
strains.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The general approach followed in this study to engineer E. coli for δ-
aminovalerate and glutarate production from glucose. The lysine biosynthesis 
pathway was allosterically deregulated, the competing cadaverine biosynthesis 
pathway was deleted, and the AMV pathway was introduced. 
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DavT, specifically, is a transaminase that requires 2-KG, for example. 
After examining the metabolism of E. coli in depth, it was hypothesized that 2-
KG limitations may not be a concern since a net of one molecule of 2-KG is 
produced for every L-lysine molecule that is produced. Together davBA convert 
L-lysine to δ-aminovalerate, one of the desired products. Then, davDT is 
responsible for converting for converting δ-aminovalerate to glutarate, the second 
desired product, for converting δ-aminovalerate to glutarate, the second desired 
product. 
A modular approach to constructing pathways for each product was 
adopted to improve efficiency.  This involved cloning and expressing the AMV 
pathway genes as part of their native operons. Therefore, as depicted in Figure 7, 
davBA was cloned from P. putida KT2440 into pSTV28, while davDT was cloned 
from P. putida KT2440 into pTRC99a, resulting in the construction of plasmids 
pSTVDavBA and pTRCDavDT.  While plasmid X in theory would provide the 
genes required for δ-aminovalerate production, when paired with the plasmid 
pCDFLysC
fbr
DapA
fbr
, the three plasmids would complete the entire pathway to 
glutarate.    
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Figure 7: Plasmid constructs for lysine pathway deregulation and 
introduction of the AMV pathway. DavBA and davDT were cloned as 
operons into the depicted restriction sites. dapA
fbr
 and lysC
fbr
 were cloned 
into the first and second cloning sites of the pCDFduet-1. 
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3.3 Results and Discussions 
3.3.1 Expression of DavBADT in E. coli 
Whole cells (BW25113) transformed with the various pathway plasmid constructs 
pSTVDavBA and/or pTRCDavDT were grown up to be used for protein analysis. 
Figure 8 below shows the protein lysate contents. As outlined in table 3, the 
predicted size of the davB protein is 61kD. This is consistent with the circled 
protein band in lane 3. However, davA was not easily seen on this gel. The 
absence of davA is unexplained, and was not found in repeat assays. However, 
since digestion and PCR colony screens of the plasmid based operon appeared 
successful it was decided to test for enzyme functionality. As explained in detail 
later, wild-type BW25113, when supplemented with L-lysine, does not produce 
any δ-aminovalerate; However, BW25113 transformed with pSTVDavBA does.  
This demonstrates that davA is expressed and functional.  
Table 3: Characteristics of the key AMV pathway enzymes 
Enzyme DavB DavA DavT DavD 
Chemistry Monooxygenase Amidohydrolase Transaminase Dehydrogenase 
Cofactors O2 H2O 2-ketoglutarate NADP
+ 
Byproducts CO2, H2O NH3 L-glutamate NADPH, 2 H
+ 
Molecular 
Weight 
61kD 67kD 44.82kD 51.55kD 
Km 620µM  2000µM 2000µM 63µM 
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Figure 8: Protein gel showing the successful expression of davB and davDT in 
BW25113. The lanes contain protein from the following sources (Left to Right): 
Precision Plus Protein DNA ladder, BW25113 pSTV28 pTRC99a (control), 
BW25113 pSTVDavBA, BW25113 pTRCDavDT, BW25113 pSTVDavBA 
pTRCDavDT (entire AMV pathway). 
0 0 
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Additionally, the protein gel depicts, in accordance with the experimental 
(when available) or predicted protein molecular weights, the successful 
expression of the proteins davD, and davT. In lane four, two bands are circled that 
correspond to davD and davT, and the molecular weights listed for them in table 
3. The last lane (all the way to the right) contained both cloned plasmids 
(BW25113 pSTVDavBA pTRCDavDT) and the same three bands. Based on the 
protein gel alone it was apparent that three of the four exogenous pathway 
proteins were being translated. Small samples of protein lysates were also taken 
for Bradford total protein assays. Based on BSA protein calibrations, total protein 
concentrations of BW25113 transformed with pSTVDavBA and pTRCDavDT 
were 1.05 and 0.89 mg/mL of total protein. Cells transformed with both 
pSTVDavBA and pTRCDavDT had 1.29 mg/mL total protein based on the assay. 
 
3.3.2 Assaying Function and Kinetics of DavBADT in E. coli 
Kinetic assays were next performed using either resting cells or cell 
lysates to determine if the pathway enzymes were functional, and to provide a 
measure of their activity in E. coli.    Collective function of DavBA was first 
studied by feeding lysine directly to resting whole cells of E. coli BW25113 in 
PBS, and monitoring its consumption together with the corresponding production 
of δ-aminovalerate (as determined by HPLC-DAD) as a function of time. The 
dynamic results are present in Figure 9, which also compares the impact of 
different initial concentrations of lysine.  It can be seen that nearly all of the lysine 
47 
 
added is efficiently converted to δ-aminovalerate in under 20 h and the amount 
produced is limited only by the initial amount of L-lysine added at the start of the 
assay. This demonstrates that DavBA are functional in E. coli, despite the 
inability to specifically detect DavA in protein gels. Using the data from Figure 9, 
yields of L-lysine-to-δ-aminovalerate through DavBA have been determined and 
are compared in Table 4 as a function of initial L-lysine concentration. 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 9: Lysine consumption kinetics and the resultant production of δ-
aminovalerate as a function of time in resting whole cell assays of E. coli 
BW25113 pSTVDavBA. Data shown are the averages of three independent 
replicates with the standard deviations calculated. Concentrations are: open 
symbols, lysine; filled symbols, AMV; Square, triangle, and circle data 
correspond to the experiments fed 2.5, 1.5, 0.5 g/L Lysine, respectively.  
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With DavBA found to be functional and capable of providing reasonable 
rates of δ-aminovalerate production from lysine, the first half of the pathway had 
been successful kinetically. Next, the second half of the pathway, namely DavDT, 
required similar testing and validation.  To do so, resting cell experiments were 
again performed, though this time on strain E. coli BW25113 pTRCDavDT and 
by adding δ-aminovalerate as a substrate.  Initially it was found that, despite the 
observance of DavD and DavT in cell extracts, little to no activity was detectable, 
as seen in Figure 10. We hypothesized that this unfavorable result could have 
arisen due to several potential limiting factors, including, non-functional enzymes 
(DavDT), poor import of δ-aminovalerate into the cells, poor export of glutarate 
out of the cells, or co-factor limitations.  A series of follow-up studies were 
Starting Lysine Concentration 
[g/L] 
Yield of [AMV]prod. /[Lys]cons. 
[mmol/mmol] 
0.46 0.948 
1.61 0.951 
2.45 0.891 
Table 4: AMV production yields from E. coli BW25113 pSTVDavBA resting 
whole cell kinetic data 
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performed to explore these prospects in an effort to achieve functional expression 
of enzymes constituting the second half of the glutarate pathway. 
 
 
 
 
 
 
 
 
 
 
 
 
3.3.3 Troubleshooting the Second Half (DavDT) of the AMV Pathway 
To test if poor import of δ-aminovalerate was limiting, resting cell assays 
with were performed on E. coli BW25113 pSTVDavBA pTRCDavDT, which 
Figure 10: AMV consumption and the resultant production of glutarate as 
a function of time in resting cell assays of E. coli BW25113 pTRCDavDT. 
Square data are AMV concentrations and circles are glutarate 
concentrations. 
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expresses both DavBA and DavDT.  As was shown in Figure 11, δ-aminovalerate 
is endogenously produced in this strain, and thus should also be available to 
DavDT in the cell. However, it was also found that, although lysine was again 
efficiently converted to δ-aminovalerate, a bottleneck then occurred in the 
pathway as a result of low DavDT activity and almost no glutarate production was 
detected.  
 
 
 
 
 
 
 
 
 
 
 
 
Figure 11: Lysine consumption and the resultant production of δ-
aminovalerate and glutarate as a function of time in resting cell assays of 
BW25113 pSTVDavBA pTRCDavDT (entire pathway): Squares (lysine), 
triangles (AMV), and circles (glutarate) 
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Next the possibility of cofactor limitations was tested because, as seen in 
Table 3, the transaminase reaction catalyzed by DavD is known to also require 2-
ketoglutarate (2-KG).  Cofactor limitations are common in resting cell assays 
because, although cells are provided with one of the required substrates (in this 
case δ-aminovalerate), because cells are not growing they are also unable to 
synthesize the required cofactor.  To test this possibility, resting cell experiments 
with strain BW25113 pTRCDavDT expressing DavDT were repeated, but in this 
case 2-KG was also provided to the cells.  In this case, a fixed concentration of δ-
aminovalerate (1.5g/L) was provided together with varying initial concentrations 
of 2-KG (0.85, 1.71, or 3.41 g/L, corresponding to 0.5, 1.0, or 2.0-times the 
stoichiometric requirement). As seen in Figures 12, 13, and 14, the addition of  2-
KG to the medium promptly led to glutarate formation, which was excreted from 
the cells to accumulate in the medium. 
While 2-KG supplementation resulted in alleviation of the bottleneck at 
DavT, the effect was clearly concentration dependent. When 2-KG is added at a 
limiting concentration, conversion of δ-aminovalerate to glutrate promptly stops 
once all 2-KG is consumed.  Likewise, when 2-KG is added at excessive 
concentrations, conversion of δ-aminovalerate to glutarate goes to completion and 
leaves residual 2-KG as unreacted in the culture.  
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At last, the function of the entire pathway (from lysine to gutarate) was 
tested in resting cells of E. coli BW25113 pSTVDavBA pTRCDavDT expressing 
DavDABT and provided with both lysine and 2-KG.  Varying the amount of 2-
KG were added (relative to its stoichiometric requirement, as based on the initial 
amount of lysine added) to again demonstrate its essential importance and how it 
can limit resting cell assays. Glutarate was efficiently produced at yields of .94 
mmol mmol
-1
 on lysine, as shown in Figure 15. Another reason to test the entire 
Figure 12: AMV consumption and the resultant production of glutarate as a 
function of time in resting whole cell assays of BW25113 pTRCDavDT 
supplemented with 0.5x stoichiometric (limiting) 2-KG: Squares represent 
AMV concentration, triangles represent 2-KG concentration, and circles 
represent glutarate formation. 
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pathway construction was to discern bottlenecks at the step of davT, or any other 
step for that matter, and if bottlenecking was happening at DavT at low cellular 
concentrations of 2-KG. However, no significant bottlenecking, as would be 
indicated by the accumulation of an intermediate was observed. 
 
 
 
  
 
 
 
 
 
 
 
 
 
Figure 13: AMV consumption and the resultant production of glutarate 
as a function of time in resting whole cell assays of BW25113 
pTRCDavDT supplemented with 1.0x stoichiometric (equimolar) 2-KG: 
Squares represent AMV concentration, triangles represent 2-KG 
concentration, and circles represent glutarate formation 
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It is possible however, that some degree of bottlenecking is taking place 
and that this experiment did not detect it. More specifically, δ-aminovaleramide 
and glutarate semialdehyde were not measured analytically due to the fact that 
these chemicals are not commercially available. It can be argued, though, that this 
bottle necking cannot be significant because the rates of AMV formation and 
glutarate formation compared to L-lysine consumption and AMV consumption, 
respectively, are comparable. 
 
 
 
 
 
 
 
 
 
 
 
Figure 14: AMV consumption and the resultant production of glutarate 
as a function of time in resting whole cell assays of BW25113 
pTRCDavDT supplemented with 2.0x stoichiometric (excessive) 2-KG: 
Squares represent AMV concentration, triangles represent 2-KG 
concentration, and circles represent glutarate formation. 
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3.3.4 Testing the Toxicity of δ-Aminovalerate and Glutarate against E. coli 
 With a functional pathway elucidated, the next objective was to integrate 
the pathway together with endogenous lysine over-production to explore the 
production of δ-aminovalerate and glutarate from glucose.  However, before 
Figure 15: Lysine consumption and the resultant production of δ-
aminovalerate and glutarate as a function of time in resting cell 
assays of BW25113 pSTVDavBA pTRCDavDT (entire pathway), 
when supplemented with 1.0x stoichiometric (equimolar) 2-KG: 
Squares (lysine), crosses (2-KG), triangles (glutarate), and circles 
(AMV) 
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doing so it is useful to first assess potential inhibitory effects that these products 
may illicit againt the E. coli host.  This knowledge will help to set a baseline for 
maximal product titers that may be expected in cultures of our engineered strains.   
Production rates of δ-aminovalerate and glutarate are essentially a function 
of cellular growth rate. If product accumulation disrupts cellular processes in one 
way or another then production rates will likely drop. If the toxicity were too high 
it may be ineffective to attempt to produce these compounds with E. coli as a 
host. As mentioned in Chapter 2, we define the toxicity limit as the point at which 
the rate of cellular growth is zero, and any further compound addition results in 
cell death. This represents the maximum achievable product titer.  
 Toxicity assays conducted by the direct addition of either δ-aminovalerate 
or glutarate to growing culture of BW25113 are shown in figures 16 and 17.  
From these tests it is apparent that E. coli can survive and grow in the presence of 
high concentrations (at least 4g/L) of both δ-aminvalerate or glutarte.  Growth 
rates were always at least 85% of that of the control strains (BW25113 grown in 
M10 without δ-aminvalerate or glutarate). The high tolerance of E. coli to these 
chemicals is ideal as it suggests that reaching titers as high as these may one day 
be possible, and that product toxicity will be of little concern at this point in the 
strain construction.  
These results coupled with those of the production kinetic studies give 
strong support for the potential of this technology to directly convert renewable 
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glucose to δ-aminovalerate and glutarate.   The next requirement is to engineer a 
host strain capable of over-producing lysine, the precursor to the AMV pathway, 
from glucose.   
 
 
 
 
 
 
 
 
 
 
3.4 Engineering a L-lysine Over-producing E. coli Strain as a Host Platform 
After discerning that the compounds of interest are not toxic to the cells, even at a 
high concentrations, and that both pathways can be functionally expressed in E. 
coli without major bottlenecks, the next step was to engineer E. coli to produce 
large quantities of L-lysine. Lysine is the pathway precursor, from glucose. 
Figure 16: Toxicity of AMV on BW25113. Glutarate concentrations: 0 g/L 
(squares), 0.5 g/L (crosses, x), 1.0 g/L (circles), 2.0 g/L (diamonds), 3 g/L 
(triangles), 4 g/L (pluses, +) 
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Resting cells could be fed lysine as a system for producing these compounds; 
however, at this point supplementation with L-lysine is not preferable because of 
costs, even though lysine production is an evolving green technology. A strain 
that can grow on glucose as a single, renewable carbon source would enable δ-
aminovalerate and glutarate production from glucose. 
 
 
 
 
 
 
 
 
 
 
 
To develop a lysine overproducing E. coli strain with the goal of achieving 
maximal lysine titers and yields was the goal. To engineer a novel lysine over-
Figure 17: Toxicity of glutarate on BW25113. Glutarate concentrations: 0 
g/L (squares),0.5 g/L (crosses, x), 1.0 g/L (triangles), 2.0 g/L (pluses, +), 
3 g/L (circles), 4 g/L (diamonds) 
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producing E. coli strain based on BW25113, as achieved by deregulating its 
natural lysine biosynthesis pathway. Lysine biosynthesis is naturally regulated by 
the feedback inhibition of two key enzymes in its production pathway.  Figure 6 
details the lysine biosynthesis pathway with the feedback inhibition illustrated. 
These enzymes are DapA and LysC, a dihydrodipicolinate synthase and aspartate 
kinase, respectively.  Feedback inhibition is a natural mechanism evolved to 
prevent precious cellular resources from being used inefficiently. However, 
feedback resistant variants of both enzymes have been evolved over the years and 
also been sequenced. It was discovered that dapA in Corynebacterium 
glutamicum 13032 is naturally a feedback resistant dihydrodipicolinate synthase. 
Additionally, using S-aminoethyl-L-cysteine as an L-lysine analog, researchers 
have developed feedback resistant aspartate kinase III. Exposure to this analog 
puts stress on cells, and in order to survive, eventually will evolve to make 
feedback resistant enzymes.  
Characterization and sequencing of lysC in one of these evolved strains 
showed a substitution at the 1055th nucleotide from a cytosine to a thymine, 
causing a mutation at the 352nd amino acid from a threonine to an isoleucine. 
Using splicing overlap extension, as described in Chapter 2, this single base pair 
mutation (Cytosine to Thymine) was introduced into lysC. 
 As schematically depicted in figure 18, this mutation changed a polar 
hydroxyl bearing carbon side chain to a strongly hydrophobic alkyl side chain. As 
lysine is extremely hydrophilic, this mutation precludes from L-lysine binding to 
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Table 5: Sequencing Results of the DNA plasmid pCDFLysC
fbr
DapA
fbr
 at the 
region of the mutation 
the active site of aspartate kinase III, thereby relieving its inhibitory effect. The 
sequence of the single point mutant was confirmed at the Biodesign Institute at 
Arizona State University using a DNA sequencing process. To illustrate, the 
DNA, and corresponding amino acid, sequencing results are provided in Table 5. 
Running a Bradford assay with BW25113 pCDFDapA
fbr
 and BW25113 
pCDFDapA
fbr
LysC
fbr
, yielded 1.05 and 1.28 mg mL
-1
 of total protein, 
respectively. 
  
       Threonine       Isoleucine 
 Figure 18: Amino acid mutation in LysC was from a threonine at the 352 
 amino acid to an isoleucine. 
 
 
 
Native lysC Nucleotide 
Sequence: 
…G AGC GTG GCA TTA ACC CTT GAT ACC ACC 
GG … 
Mutated lysC Sequence : … G AGC GTG GCA TTA ATC CTT GAT ACC ACC 
GG … 
Native lysC Amino Acid 
Sequence: 
… L I T T S E V S V A L T L D T T G S T S … 
Mutated lysC Amino Acid 
Sequence  
… L I T T S E V S V A L I L D T T G S T S … 
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Table 6:  Lysine and cadaverine production in BW25113 pCDFDapA
fbr
 and 
BW25113 pCDFLysC
fbr
DapA
fbr
. Tabulated data calculated as averages of 
duplicate experiments. 
 
 
3.4.1 Experiments of L-lysine Over-production in E. coli  
Co-expression of dapA
fbr 
and lysC
fbr
 in E. coli BW25113 
pCDFLysC
fbr
DapA
fbr 
was next evaluated for its ability to enable lysine over-
production.   This strain was grown in M10 media and induced by the addition of 
12.5 µL 1 M IPTG after 3 h of growth. First the effects of the individual gene 
dapA
fbr
 was compared head to head with BW25113 pCDFLysC
fbr
DapA
fbr
. 
 
 
 
 
 
BW25113 pCDFDapA
fbr
 BW25113 
pCDFLysC
fbr
DapA
fbr
 
Time L-lysine 
[g/L]
 
Cadaverine 
[g/L] 
L-lysine 
[g/L]
 
Cadaverine 
[g/L] 
0 0 0 0 0 
5.25 0.136 0.05 0.155 0.05 
18.25 0.784 0.15 0.716 0.358 
48 0.154 0.82 0.27 0.64 
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Since it was apparent in these experiments (Table 6) that the addition of 
both dapA
fbr
 and lysC
fbr 
was better than just dapA
fbr
 for lysine production, for all 
further experiments only this plasmid (pCDFLysC
fbr
DapA
fbr
) was used. It is 
intuitive that the addition of both feedback resistant genes would lead to the best 
lysine producer. The regulation of the lysine biosynthesis pathway occurs 
allosterically at both locations, and if only a single feedback resistant enzyme is 
introduced then feedback inhibition can still occur. Since the lysine production 
was markedly depressed after the 18 hour mark in these producers, it was 
reasoned that the elimination of the cadaverine biochemical pathway, which 
diverts flux away from the AMV pathway, could further increase titers. 
Cadaverine is a natural lysine degradation product of E. coli.  In E. coli it is 
known that there are two different L-lysine decarboxylase enzymes, cadA and 
ldcC. The former is an acid inducible enzyme with a pH optimum of 5, whereas 
ldcC is constitutively expressed by a weak promoter. 
With regards to maximizing AMV and glutarate production, cadaverine 
coproduction is problematic as it competes for lysine, the required pathway 
precursor.  Therefore, we hypothesized that the deletion of this competing 
pathway could further increase lysine accumulation, and therefore its availability 
to our pathways. BW25113 with single deletions of both ldcC and cadA were 
purchased from the Keio collection (Mori et al. 2006). BW25113 ldcC and 
BW25113 cadA were subsequently evaluated for lysine production upon their 
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transformation with pCDFLysC
fbr
DapA
fbr
, the results of which are compared in 
Figure 19. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
  
 From Figure 19 it is apparent that after about 18 h mark BW25113 cadA 
becomes the superior lysine over-producer. However, cadaverine production was 
still a problem, albeit less than the wild-type, in both single gene knockout strains. 
It was reasoned that BW25113 ldcC performed less ideally than BW25113 
Figure 19: Lysine and cadaverine production in BW25113cadA and 
BW25113ldcC (l-lysine decarboxylase knockout strains):  Squares 
(BW25113cadA), circles (BW25113ldcC), triangles (BW25113 wild-type); 
Filled symbols are lysine data points and open symbols are cadaverine data 
points. 
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cadA because after a certain amount of culturing time, the pH of the media 
dropped to a level in which cadA transcription increased to a significant level. The 
pH of the cultures at 48h was approximately 5 (the optimal pH of cadA).   
 
 
 
 
 
 
 
 
 
 
. 
 
 
 
 
Also, BW25113 cadA still produced cadaverine because ldcC is weakly 
constitutive, and is always being expressed. This hints to the fact that a double 
mutant, BW25113cadAldcC, may actually be the best option, as long as 
complete elimination of the cadaverine biochemical pathway does not affect 
Figure 20: Growth characteristics of pCDFLysC
fbr
DapA
fbr
 bearing 
strains and single mutants: Squares (BW25113 wild-type), crosses 
(BW25113 pCDFLysC
fbr
DapA
fbr
), circles (BW25113cadA 
pCDFLysC
fbr
DapA
fbr
), and triangles (BW25113ldcC 
pCDFLysC
fbr
DapA
fbr
) 
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cellular function as a whole. However, it can be argued that in a fermenter of any 
appreciable size (≥ 1L) there will be control of pH, agitation speed (dissolved 
oxygen), and glucose levels. With pH control, the BW25113 ldcC will be 
essentially the same phenotypically as BW25113 cadAldcC, because the acid-
inducible, acid optimal cadA will not be translated. 
With the addition of the AMV pathway, it is possible that most lysine will 
not be available for the L-lysine decarboxylase enzymes. For these reasons, AMV 
and glutarate production experiments (Figures 21 and 23) were done in 
BW25113ldcC while a double mutant (BW25113 cadAldcC) was developed. 
Growth experiments showed that BW25113 cadA and BW25113 ldcC 
had no effect on the growth rate or final OD600 (compared to wild type) of cell 
cultures during production transformed with pCDFLysC
fbr
DapA
fbr
, as seen in 
Figure 20. In light of these considerations, subsequent studies focused on the 
engineering of a lysine over-producing strain emphasized the use of strains 
derived of BW25113 cadA and BW25113 ldcC and which were transformed 
with pCDFLysC
fbr
DapA
fbr
.  
 
3.5 AMV and Glutarate Production Experiments on Glucose 
 
With all of the pieces in place, a functional pathway and a developed lysine 
producing host strain, it was appropriate to test for the production of AMV and 
then glutarate on M10 glucose media.  Experiments were begun with the same 
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Figure 21: AMV production curve of E. coli BW25113ldcC 
pCDFLysC
fbr
DapA
fbr
 pSTVDavBA grown in M10 media. Triangles 
represent AMV concentration, circles represent cadaverine concentration, 
squares represent lysine concentration, and crosses represent glutarate 
concentration. 
 
procedures as before but with the strains E. coli BW25113 ldcC 
pCDFLysC
fbr
DapA
fbr
 pSTVDavBA and E. coli BW25113 ldcC 
pCDFLysC
fbr
DapA
fbr
 pSTVDavBA pTRCDavDT. This strain is what is depicted 
in figure 6. Seed cultures were grown up and 50mL M10 innoculated and 
induced. Experiments were repeated in triplicate.  
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Figure 22: Glucose consumption and growth curve of E. coli 
BW25113ldcC pCDFLysCfbrDapAfbr pSTVDavBA grown in M10 media. 
Triangles represent glucose and squares represent OD600 measurements. 
 
Figure 21 above, depicts the metabolite concentrations of the constructed 
AMV producing strain. After 48 hours of growth over 0.86 g/L AMV 
accumulated in the culture with minimal accumulation of byproducts cadaverine, 
lysine, or glutarate (a byproduct when AMV production is desired). As depicted 
in the AMV produced versus glucose consumed plot (Figure 25) the yield of 
AMV remained fairly steady at 69.5 mmol/mol with a specific growth rate of 
0.243 h
-1 
(calculated from figure 22) Additionally, it can be seen from Figure 22 
that the media was not completely exhausted at 48 hours, and may have had 
potential for a higher cell density and AMV titer. 
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Figure 23: Glutarate production curve of E. coli BW25113ldcC 
pCDFLysC
fbr
DapA
fbr
 pSTVDavBA pTRCDavDT (entire AMV pathway) 
grown in M10 media. Triangles represent glutarate concentration, circles 
represent cadaverine concentration, squares represent lysine 
concentration, and crosses represent AMV concentration. 
 
 Next the entire pathway was constructed to check for a glutarate 
producing phenotype. As depicted in figure 23 glutarate was also accumulated to 
an appreciable titer of 0.82 g/L in 48 h at a fairly constant yield of 68.4 mmol/mol. 
As was the case in figure 22, figure 24 shows the media was nearly exhausted and 
a longer culture could potentially reach higher glutarate titer and cell density. 
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Figure 24: Glucose consumption and growth curve of E. coli 
BW25113ldcC pCDFLysCfbrDapAfbr pSTVDavBA pTRCDavDT grown 
in M10 media. Triangles represent glucose and squares represent OD600 
measurements. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
This demonstrates the first microbial overproduction of both AMV and 
glutarate to titers of 0.86 and 0.82 g/L, respectively at 48 hours. Side product 
formation was present, but minimal in the production strains with the functional 
AMV pathway diverting flux from lysine. These results are promising, and 
support further research toward the development of AMV and glutarate 
production using metabolic engineering and microbe based biotechnology. 
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Figure 25: AMV and Glutarate produced as a function of glucose 
consumed in E. coli BW25113ldcC pCDFLysCfbrDapAfbr 
pSTVDavBA pTRCDavDT grown in M10 media. Squares represent 
AMV produced and circles represent glutarate produced. 
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Chapter 4 
CONCLUSIONS AND FUTURE WORK 
 
4.1 Conclusions 
Volatile oil prices, environmental concerns, and finite oil reserves are 
strong motivating factors for the development of a bio-based, sustainable society. 
With few exceptions, most conventional polymers are derived from these non-
renewable and polluting petroleum resources. Sustainable methods that meet our 
polymer material demands must be discovered, and polyamide whose molecular 
building blocks are ubiquitously petrochemicals, are not the exception. In the year 
2010 alone there was a global market demand of 3.5 million tons of various 
polyamides. The functionality of these polyamide monomers is similar to many in 
vivo metabolites (i.e. γ-aminobutyrate, cadaverine, succinate) making a 
sustainable biosynthetic production route to these monomers feasible. However, 
to date there have been no useful homopolyamide, or homopolyamide precursors 
produced microbially on glucose. Additionally, there have been no other 
dicarboxylic acids produced in a sustainable manner, aside from the natural 
metabolite succinate, thus limiting the potential types of sustainable polyamides 
that can be produced renewably. The demonstration herein of the sustainable 
production of glutarate and δ-aminovalerate helps push this field forward by 
filling these gaps.  
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First, a lysine degradation pathway found in Pseudomonas sp. was 
reconstructed in E. coli BW25113 which passes through δ-aminovaleric acid  and 
glutaric acid. The respective pathway enzymes were cloned into expression 
vectors and tested for enzyme production and functionality. Because of its 
tractability, E. coli was developed into a lysine over-producer through 
deregulation of the native lysine superpathway through over-expression of 
feedback resistant lysC
fbr
 and dapA
fbr
, aspartate kinase and dihydrodipicolinate 
synthase, respectively. The AMV pathway was then constructed with genes from 
E. coli, C. glutamicum, and P. putida and imparted to the best lysine over-
producing strains to test for novel δ-aminovaleric acid and/or glutaric acid 
production. Final titers of 0.86 and 0.82 g/L, respectively in forty-eight hours 
were achieved with yields of 69.5 mmol AMV mol
-1 
glucose and 68.4 mmol 
Glutarate mol
-1 
glucose.  
 
4.2 Future Work 
This project signals the proof of concept for the production of AMV and 
glutarate from glucose. There are many aspects of the process that must logically 
next be addressed to move forward with this project. Creation of a double mutant 
of both ΔcadAΔldcC would seemingly be ideal and could possibly increase flux 
toward the reconstructed AMV pathway and reduce cadaverine formation 
completely. This could be done following Datsenko and Wanner’s well-known 
gene knockout procedure (Wanner et al., 2000). 
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 Flux to lysine is another important aspect of the project. The major 
limiting factor is the amount of glucose that is eventually converted to lysine. 
Once the lysine is present the vast majority is funneled through the AMV 
pathway. Further increasing flux to lysine through upstream modifications would 
be desirable. There are currently Corynebacterium strains that produce millions of 
tons of lysine per year, and modeling some of these characteristics in E. coli could 
lead to increasing results. Or alternatively, now that this concept has been 
demonstrated in the tractable E. coli, reconstructing the pathway inside of a 
suitable Corynebacterium strain, with compatible expression vectors, could 
potentially lead to an outstanding AMV and Glutarate producing strain.  
 Another future point of work will undoubtedly be the scale-up process. 
One major limitation of these experiments was that each production experiment 
was limited to batch shake flasks. Batch shake flasks are less than ideal because 
of the conditions of the experiments are poorly controlled. A scale-up to a 
laboratory sized fermenter with on-line temperature, dissolved oxygen, pH, and 
glucose concentration control would more than likely lead to titers much higher 
than those demonstrated herein, even without altering the production strains any 
further. 
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